Share this article
Share this article
ResearchAndMarkets.com s offering.
The global vaccine contract manufacturing market by revenue is expected to grow at a CAGR of approx 13% during the period 2020-2026.
The global vaccine contract manufacturing market has experienced radical transformations after the outbreak of the COVID-19 pandemic, which has been a massive health catastrophe.
Vaccine CMOs have gained significant attention as the virus starts spreading far and wide. A new era of vaccine and biological drug development has prevailed since the advent of the COVID-19 virus. The global pandemic has fueled vaccine innovations with the rapid acceleration of RNA-based COVID vaccines. Contract manufacturing companies are working to increase the availability of COVID-19 vaccines across the globe.
The global vaccine contract manufacturing market by revenue is expected to grow at a CAGR of approx. 13% during the period 2020–2026 In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Vaccine Contract Manufacturing Market Report. The global vaccine contract manufacturing market by revenue is expected to grow at a CAGR of approx.
April 16, 2021 09:32 ET | Source: ReportLinker ReportLinker Lyon, FRANCE
New York, April 16, 2021 (GLOBE NEWSWIRE) Reportlinker.com announces the release of the report Vaccine Contract Manufacturing Market - Global Outlook and Forecast 2021-2026 - https://www.reportlinker.com/p06063357/?utm source=GNW 13% during the period 2020–2026.
The global vaccine contract manufacturing market has experienced radical transformations after the outbreak of the COVID-19 pandemic, which has been a massive health catastrophe. Vaccine CMOs have gained s
(0)
CHICAGO, April 14, 2021 /PRNewswire/ In-depth analysis and data-driven insights on the impact of COVID-19 included in this global vaccine contract manufacturing market report.
The vaccine contract manufacturing market is expected to grow at a CAGR of approximately 13% during the period 2020-2026.
Key Highlights Offered in the Report:
The global vaccine contract manufacturing market is expected to grow with an incremental growth of around USD 2 billion and absolute growth of around 104% during the forecast period.
In scale of operation, the commercial segment has the highest share of around 64% due to high uptake of vaccines as well as growing vaccine pipeline and is likely to witness highest incremental growth of around USD 1.3 billion during the forecast period.